X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2126) 2126
Publication (107) 107
Book Review (45) 45
Book Chapter (15) 15
Book / eBook (14) 14
Newsletter (11) 11
Magazine Article (7) 7
Trade Publication Article (4) 4
Newspaper Article (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1898) 1898
histamine h2 antagonists - therapeutic use (975) 975
male (917) 917
female (839) 839
histamine h2 antagonists - adverse effects (770) 770
middle aged (609) 609
adult (591) 591
aged (519) 519
index medicus (501) 501
proton pump inhibitors (351) 351
histamine h2 antagonists - administration & dosage (306) 306
histamine (305) 305
risk factors (304) 304
pharmacology & pharmacy (275) 275
animals (270) 270
anti-ulcer agents - therapeutic use (259) 259
anti-inflammatory agents, non-steroidal - adverse effects (247) 247
gastroenterology & hepatology (236) 236
ranitidine (213) 213
histamine h2 antagonists - pharmacology (200) 200
peptic ulcer - drug therapy (194) 194
proton pump inhibitors - adverse effects (186) 186
proton pump inhibitors - therapeutic use (185) 185
treatment outcome (184) 184
ranitidine - adverse effects (181) 181
anti-ulcer agents - adverse effects (175) 175
aged, 80 and over (171) 171
medicine, general & internal (169) 169
ranitidine - therapeutic use (167) 167
adolescent (166) 166
double-blind method (159) 159
omeprazole (153) 153
time factors (153) 153
cimetidine - adverse effects (147) 147
drug interactions (145) 145
double-blind (142) 142
drug therapy, combination (141) 141
cimetidine (134) 134
duodenal ulcer - drug therapy (133) 133
histamine h1 antagonists - therapeutic use (133) 133
risk (132) 132
retrospective studies (131) 131
cimetidine - therapeutic use (130) 130
antacids - therapeutic use (128) 128
gastroesophageal reflux - drug therapy (125) 125
clinical trials as topic (114) 114
omeprazole - therapeutic use (108) 108
therapy (106) 106
dose-response relationship, drug (105) 105
rats (105) 105
famotidine (104) 104
peptic ulcer - prevention & control (102) 102
allergy (98) 98
prevention (97) 97
drug therapy (95) 95
helicobacter pylori (94) 94
stomach ulcer - drug therapy (94) 94
helicobacter infections - drug therapy (93) 93
gastric mucosa - drug effects (88) 88
ranitidine - administration & dosage (88) 88
recurrence (88) 88
child (86) 86
gastric acid - secretion (86) 86
nonsteroidal antiinflammatory drugs (86) 86
drug administration schedule (85) 85
prospective studies (85) 85
peptic ulcer - chemically induced (83) 83
medicine & public health (81) 81
proton pump inhibitor (81) 81
care and treatment (78) 78
drugs (78) 78
famotidine - therapeutic use (78) 78
research (77) 77
aspirin - adverse effects (76) 76
case-control studies (76) 76
incidence (76) 76
gastroesophageal reflux (73) 73
health aspects (73) 73
omeprazole - adverse effects (73) 73
immunology (72) 72
surgery (72) 72
ulcers (70) 70
famotidine - adverse effects (69) 69
stomach ulcer - prevention & control (69) 69
proton pump inhibitors - administration & dosage (68) 68
anti-ulcer agents - administration & dosage (67) 67
disease (67) 67
abridged index medicus (66) 66
stomach ulcer - chemically induced (66) 66
cimetidine - pharmacology (65) 65
antacids - adverse effects (64) 64
gastric acid - metabolism (63) 63
internal medicine (63) 63
administration, oral (62) 62
histamine h1 antagonists - pharmacology (61) 61
young adult (61) 61
dosage and administration (60) 60
follow-up studies (60) 60
oncology (60) 60
proton-pump inhibitors (60) 60
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1900) 1900
German (76) 76
Japanese (74) 74
Spanish (29) 29
French (23) 23
Russian (14) 14
Italian (11) 11
Danish (9) 9
Dutch (8) 8
Bulgarian (4) 4
Chinese (4) 4
Norwegian (4) 4
Portuguese (3) 3
Hebrew (2) 2
Hungarian (2) 2
Korean (2) 2
Swedish (2) 2
Arabic (1) 1
Finnish (1) 1
Polish (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 12/2010, Volume 122, Issue 24, pp. 2619 - 2633
proton pump inhibitors | antiplatelet drugs | gastrointestinal hemorrhage | platelet aggregation inhibitors | aspirin | thienopyridine | AHA Scientific Statements | CARDIAC & CARDIOVASCULAR SYSTEMS | CARDIOVASCULAR EVENTS | TRANSIENT ISCHEMIC ATTACK | ACID SUPPRESSION | ACUTE CORONARY SYNDROMES | H-2-RECEPTOR ANTAGONISTS | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ACUTE MYOCARDIAL-INFARCTION | PERIPHERAL VASCULAR DISEASE | PLACEBO-CONTROLLED TRIAL | ST-SEGMENT ELEVATION | Piperazines - administration & dosage | Prasugrel Hydrochloride | Purinergic P2Y Receptor Antagonists - administration & dosage | Thiophenes - adverse effects | Cardiovascular Diseases - drug therapy | Humans | Thienopyridines - adverse effects | Thienopyridines - metabolism | Piperazines - metabolism | Thiophenes - metabolism | Thiophenes - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - metabolism | Histamine H2 Antagonists - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Aspirin - metabolism | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - metabolism | Ticlopidine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Platelet Aggregation Inhibitors - metabolism | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Thienopyridines - administration & dosage | Risk Factors | Histamine H2 Antagonists - adverse effects | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Aryl Hydrocarbon Hydroxylases - metabolism | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Histamine H2 Antagonists - metabolism | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Cytochrome P-450 CYP2C19 | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Proton Pump Inhibitors - metabolism
Journal Article
The American Journal of Gastroenterology, ISSN 0002-9270, 12/2010, Volume 105, Issue 12, pp. 2533 - 2549
This expert consensus document was developed by the American College of Cardiology Foundation (ACCF), the American College of Gastroenterology (ACG), and the... 
proton pump inhibitors | aspirin | ACCF Expert Consensus Document antiplatelet drugs | gastrointestinal hemorrhage | thienopyridine | platelet aggregation inhibitors | CARDIOVASCULAR EVENTS | TRANSIENT ISCHEMIC ATTACK | ACID SUPPRESSION | ACUTE CORONARY SYNDROMES | H-2-RECEPTOR ANTAGONISTS | LOW-DOSE ASPIRIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | ACUTE MYOCARDIAL-INFARCTION | PLACEBO-CONTROLLED TRIAL | ST-SEGMENT ELEVATION | GASTROENTEROLOGY & HEPATOLOGY | Piperazines - administration & dosage | Prasugrel Hydrochloride | Purinergic P2Y Receptor Antagonists - administration & dosage | Thiophenes - adverse effects | Cardiovascular Diseases - drug therapy | Humans | Thienopyridines - adverse effects | Thienopyridines - metabolism | Piperazines - metabolism | Thiophenes - metabolism | Thiophenes - administration & dosage | Aspirin - administration & dosage | Purinergic P2Y Receptor Antagonists - metabolism | Histamine H2 Antagonists - administration & dosage | Purinergic P2Y Receptor Antagonists - adverse effects | Drug Interactions | Proton Pump Inhibitors - administration & dosage | Aspirin - adverse effects | Aspirin - metabolism | Platelet Aggregation Inhibitors - administration & dosage | Ticlopidine - adverse effects | Ticlopidine - metabolism | Ticlopidine - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - metabolism | Platelet Aggregation Inhibitors - metabolism | Drug Therapy, Combination | Platelet Aggregation Inhibitors - adverse effects | Proton Pump Inhibitors - adverse effects | Thienopyridines - administration & dosage | Risk Factors | Histamine H2 Antagonists - adverse effects | Piperazines - adverse effects | Ticlopidine - analogs & derivatives | Aryl Hydrocarbon Hydroxylases - metabolism | Gastrointestinal Hemorrhage - chemically induced | Gastrointestinal Hemorrhage - prevention & control | Histamine H2 Antagonists - metabolism | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Cytochrome P-450 CYP2C19 | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Proton Pump Inhibitors - metabolism
Journal Article
Journal Article
Journal Article